Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
GLP-1 receptor activation suppresses appetite, slows gastric emptying, enhances glucose-dependent insulin secretion, and helps restrain inappropriate glucagon activity
Semaglutide is a GLP-1 analogue approved as a once-weekly, subcutaneous treatment for T2D [5, 6]
Ozempic slows down how quickly your stomach empties, so you stay fuller for longer and eat less
Its once-weekly formulation has proven convenient for patients, contributing to adherence to treatment regimens
However, many patients report fewer side effects with Tirzepatide and a lower need for ongoing dose increases
US$ 21.75
US$ 26.87
US$ 23.77
US$ 21.95
US$ 21.16
US$ 28.60
